Advisor Group Holdings, Inc. 180 Life Sciences Corp. Transaction History

Advisor Group Holdings, Inc.

  • $43.4 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.12 - $1.31 $24 - $262
-200 Reduced 9.64%
1,875 $1,000
Q1 2022

May 04, 2022
BUY
$2.53 - $3.9 $910 - $1,404
360 Added 20.99%
2,075 $6,000
Q3 2021

Nov 05, 2021
BUY
$5.11 - $10.81 $7,741 - $16,377
1,515 Added 757.5%
1,715 $9,000
Q2 2021

Aug 02, 2021
BUY
$6.7 - $11.98 $1,340 - $2,396
200 New
200 $2,000

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $61.1M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email